Dichos y Refranes

Descargar Face 2 Face Pre Intermediate en RTF

Face 2 Face Pre Intermediate RTF, página 6

Face 2 Face Pre Intermediate: 3770 Libros RTF

  1. Table of Contents UNITED STATES SECURITIES AND EXCHANGE ...

     
    Tipo: Documento de Texto Enriquecido
    Prior to the Merger, Intra-Cellular sold to accredited investors approximately $60.0 million ... Our lead product candidate, ITI-007, is in Phase 2 clinical trials as a ... of any Licensed Compound or an intermediate or starting material reasonably ... united states securities and exchange commission.
    https://investor.alkermes.com/static-files/73fcd665-4d49-4749-ab9d-34d681546049
  2.  
    Tipo: Documento de Texto Enriquecido

  3. Diesel Systems Technician (I470605)

     
    Tipo: Documento de Texto Enriquecido
    Prior to the Merger, Intra-Cellular sold to accredited investors approximately $60.0 million ... Our lead product candidate, ITI-007, is in Phase 2 clinical trials as a ... of any Licensed Compound or an intermediate or starting material reasonably ... united states securities and exchange commission.
    http://www.fldoe.org/core/fileparse.php/18703/urlt/I470605-1920.rtf

  4. UNITED STATES SECURITIES AND EXCHANGE COMMISSION ...

     
    Tipo: Documento de Texto Enriquecido
    Prior to the Merger, Intra-Cellular sold to accredited investors approximately $60.0 million ... Our lead product candidate, ITI-007, is in Phase 2 clinical trials as a ... of any Licensed Compound or an intermediate or starting material reasonably ... united states securities and exchange commission.
    http://ir.gogoair.com/static-files/c366704c-1954-49c7-bfbd-50961a69c1b3

  5. Download DOC

     
    Tipo: Documento de Texto Enriquecido
    Prior to the Merger, Intra-Cellular sold to accredited investors approximately $60.0 million ... Our lead product candidate, ITI-007, is in Phase 2 clinical trials as a ... of any Licensed Compound or an intermediate or starting material reasonably ... united states securities and exchange commission.
    https://ir.ocugen.com/static-files/4b4c2da5-8ca7-43da-8f01-87c815834021

  6. Download DOC

     
    Tipo: Documento de Texto Enriquecido
    Prior to the Merger, Intra-Cellular sold to accredited investors approximately $60.0 million ... Our lead product candidate, ITI-007, is in Phase 2 clinical trials as a ... of any Licensed Compound or an intermediate or starting material reasonably ... united states securities and exchange commission.
    https://ir.fulcrumtx.com/static-files/75c63187-cbcb-49c5-83c5-efa27c774136

  7. UNITED STATES SECURITIES AND EXCHANGE COMMISSION ...

     
    Tipo: Documento de Texto Enriquecido
    Prior to the Merger, Intra-Cellular sold to accredited investors approximately $60.0 million ... Our lead product candidate, ITI-007, is in Phase 2 clinical trials as a ... of any Licensed Compound or an intermediate or starting material reasonably ... united states securities and exchange commission.
    http://ir.ultragenyx.com/static-files/2bc4d564-efd7-4a06-ba7b-10414c08da34

  8. Download DOC

     
    Tipo: Documento de Texto Enriquecido
    Prior to the Merger, Intra-Cellular sold to accredited investors approximately $60.0 million ... Our lead product candidate, ITI-007, is in Phase 2 clinical trials as a ... of any Licensed Compound or an intermediate or starting material reasonably ... united states securities and exchange commission.
    https://biontechse.gcs-web.com/static-files/3b3d1105-26d7-4854-8173-25db8ca6e116

  9. united states securities and exchange commission

     
    Tipo: Documento de Texto Enriquecido
    Prior to the Merger, Intra-Cellular sold to accredited investors approximately $60.0 million ... Our lead product candidate, ITI-007, is in Phase 2 clinical trials as a ... of any Licensed Compound or an intermediate or starting material reasonably ... united states securities and exchange commission.
    https://ir.intracellulartherapies.com/static-files/20d813d0-6fdf-4273-82c4-c7a7f75f9d80

Libro en otros formatos:


Arriba